in addition , by 12 mo the treatment group exhibited ( a ) a 13.2 +/- 5.1 % increase in metaphyseal ( p less than 0.001 ) and a 2.1 +/- 0.4 % increase in diaphyseal ( p less than 0.05 ) forearm bone mass , and ( b ) significant decreases in cortical and endosteal osteoclast number .
C0262950
bone
C0222658
endosteal